Browsing by Title

HIV-1 diversity in an antiretroviral treatment naïve cohort from Bushbuckridge, Mpumalanga Province, South Africa

Msimanga, Patrick Wela; Vardas, Efthyia; Engelbrecht, Susan (BioMed Central, 2015-02)

Background South Africa has a generalized and explosive HIV/AIDS epidemic with the largest number of people infected with HIV-1 in the world. Molecular investigations of HIV-1 diversity can help enhance interventions ...

HIV-1 Drug resistance mutations in HIV-1 positive pediatric patient failing antiretroviral therapy

Claassen M; Van Zyl GU; Preiser W (2009)

HIV-1 Genetic diversity in Cape Town, South Africa, 1984 to 2004

Engelbrecht S; Jacobs GB; Laten JD; Loxton AG; Robson BA; Janse van Rensburg E (2005)

HIV-1 genetic diversity in the Cape Metropole of South Africa, 2002 to 2004.

Jacobs GB; Laten JD; Preiser W; Engelbrecht S (2007)

HIV-1 molecular diversity and drug resistance mutations amongst immuno-competent, therapy naïve infants/children and adults in Yaounde, Cameroon

Gichana, Josiah Otwoma (Stellenbosch : Stellenbosch University, 2017-12)

Background: In Cameroon, HIV infections range between 550, 000 to 690, 000 for adults aged 15 to 49 years and a prevalence rate at 4.5%. In children of 0 – 14 years, HIV infections range between 34, 000 to 44, 000. The ...

HIV-1 neutralization serotype discovery program: collection of patient samples

Preiser W (2008)

HIV-1 Phylogenetic Analysis of a patient cohort from Khayelitsha

Jacobs GB; De Beer C; Fincham JE; Adams VJ; Janse Van Rensburg E; Engelbrecht S (2005)

HIV-1 recombinants identified in Mpumalanga and Eastern Cape Provinces of South Africa

Engelbrecht S; Msimanga P; Vardas E; Glashoff RH (2010)

HIV-1 recombinants in Mpumalanga Province, South Africa

Engelbrecht S; Msimanga P; Wilkinson E; Glashoff RH; Vardas E (2010)

HIV-1 subtype C envelope function becomes less sensitive to N-glycosylation deletion during disease progression

Lumngwena, Evelyn N.; Shuping, Liliwe; Bernitz, Netanya; Woodman, Zenda (BMC (part of Springer Nature), 2019-06-17)

Objective: As part of a larger study to understand how Envelope N-glycosylation influences HIV-1 pathogenesis, we selected a participant infected with a single Subtype C variant and determined whether deletion of specific ...

HIV-1 subtype C tat and HIV-associated dementia in South Africa

Isaacs S; Glashoff RH; Engelbrecht S (2010)

HIV-1 Subtypes B and C Unique Recombinant Forms (URFs) and transmitted drug resistance identified in the Western Cape Province, South Africa

Jacobs, Graeme Brendon; Wilkinson, Eduan; Isaacs, Shahieda; Spies, Georgina; De Oliveira, Tulio; Seedat, Soraya; Engelbrecht, Susan (Public Library of Science, 2014-03)

South Africa has the largest worldwide HIV/AIDS population with 5.6 million people infected and at least 2 million people on antiretroviral therapy. The majority of these infections are caused by HIV-1 subtype C. Using ...